UMIN-CTR Clinical Trial

Recruitment status Preinitiation
Unique ID issued by UMIN UMIN000048314
Receipt No. R000055059
Scientific Title Impacts of trans-anal tube placement in patients with sigmoid colon cancer: Risk verification analysis using inverse probability weighting analysis
Date of disclosure of the study information 2022/07/15
Last modified on 2022/07/07 (Ver. 1)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Impacts of trans-anal tube placement in patients with sigmoid colon cancer
Acronym Impacts of TDT in patients with sigmoid colon cancer
Scientific Title Impacts of trans-anal tube placement in patients with sigmoid colon cancer: Risk verification analysis using inverse probability weighting analysis
Scientific Title:Acronym Impact of TDT following sigmoidectomy
Region
Japan

Condition
Condition Sigmoid colon cancer
Classification by specialty
Gastrointestinal surgery
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 To determine the factors affecting the association between TDT placement and anastomotic leakage.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes the presence or absence of anastomotic leakage
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control No treatment
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 2
Purpose of intervention Treatment
Type of intervention
Device,equipment
Interventions/Control_1 Trans anal tube placement
Interventions/Control_2 non trans anal tube placement
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
90 years-old >
Gender Male and Female
Key inclusion criteria The sigmoid colon cancer patients who underwent sigmoidectomy
Key exclusion criteria emergency surgery
Target sample size 400

Research contact person
Name of lead principal investigator
1st name Tetsuro
Middle name
Last name Tominaga
Organization Nagasaki University Graduate School of Biological Sciences
Division name Surgical oncology
Zip code 8528156
Address 1-7-1 Sakamoto, Nagasaki 852-8501, Japan
TEL 0958197304
Email tetsuro.tominaga@nagasaki-u.ac.jp

Public contact
Name of contact person
1st name Tetsuro
Middle name
Last name Tominaga
Organization Nagasaki University Graduate School of Biological Sciences
Division name Surgical oncology
Zip code 8528156
Address 1-7-1 Sakamoto, Nagasaki 852-8501, Japan
TEL 0958197304
Homepage URL
Email tetsuro.tominaga@nagasaki-u.ac.jp

Sponsor
Institute Nagasaki University Graduate School of Biological Sciences
Institute
Department

Funding Source
Organization Nagasaki University Graduate School of Biological Sciences
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Clinical Research Review Boards of Nagasaki university hospitals
Address 1-7-1 Sakamoto, Nagasaki, Japan
Tel 0958197256
Email ssato@nagasaki-u.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2022 Year 07 Month 15 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Preinitiation
Date of protocol fixation
2016 Year 04 Month 01 Day
Date of IRB
Anticipated trial start date
2016 Year 04 Month 01 Day
Last follow-up date
2022 Year 12 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2022 Year 07 Month 07 Day
Last modified on
2022 Year 07 Month 07 Day


Link to view the page
URL(English) https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000055059